Insider Trading Activity ResMed (NYSE:RMD) – Director Sold 28,403 shares of Stock

ME Staff
-
0

Insider Trading Activity For ResMed (NYSE:RMD)

Gary W Pace , Director of ResMed (NYSE:RMD) reportedly Sold 28,403 shares of the company’s stock at an average price of 97.37 for a total transaction amount of $2,765,600.11 SEC Form

Insider Trading History For ResMed (NYSE:RMD)

  • On 8/8/2012 Michael J Farrell, Insider, sold 30,000 with an average share price of $35.58 per share and the total transaction amounting to $1,067,400.00.
  • On 2/4/2013 Robert Andrew Douglas, COO, sold 8,000 with an average share price of $44.14 per share and the total transaction amounting to $353,120.00.
  • On 5/8/2013 Brett Sandercock, CFO, sold 28,000 with an average share price of $48.97 per share and the total transaction amounting to $1,371,160.00.
  • On 5/13/2013 Michael A Quinn, Director, sold 15,000 with an average share price of $50.94 per share and the total transaction amounting to $764,100.00.
  • On 5/22/2013 John P Wareham, Director, sold 18,000 with an average share price of $50.20 per share and the total transaction amounting to $903,600.00.
  • On 5/24/2013 Christopher G Roberts, Director, sold 20,000 with an average share price of $49.45 per share and the total transaction amounting to $989,000.00.
  • On 6/3/2013 Robert Andrew Douglas, COO, sold 8,000 with an average share price of $47.96 per share and the total transaction amounting to $383,680.00.

    • Analyst Ratings History For ResMed (NYSE:RMD)

    • On 2/6/2017 Canaccord Genuity Reiterated Rating Hold with a price target of $59.00
    • On 8/2/2017 Bank of America Downgraded rating Buy ➝ Neutral
    • On 8/8/2017 Credit Suisse Group Downgraded rating Outperform ➝ Neutral
    • On 10/12/2017 Jefferies Group Reiterated Rating Sell with a price target of $56.00
    • On 10/27/2017 Barclays Boost Price Target of rating Underweight with a price target of $68.00 ➝ $70.00
    • On 10/30/2017 JPMorgan Chase Boost Price Target of rating Overweight with a price target of $72.00 ➝ $73.00
    • On 1/23/2018 BMO Capital Markets Boost Price Target of rating Market Perform with a price target of $90.00

    Dividend Information For ResMed (NYSE:RMD)
    ResMed (NYSE:RMD) pays an annual dividend of $1.40 with a yield of 1.38% and an average dividend growth of 8.70% (3 Year Average).

    Dividend History For ResMed (NYSE:RMD)

  • On 1/25/2013 ResMed announced a quarterly dividend of $0.17 1.41% with an ex dividend date of 2/14/2013 which will be payable on 3/19/2013.
  • On 4/29/2013 ResMed announced a quarterly dividend of $0.17 1.44% with an ex dividend date of 5/17/2013 which will be payable on 6/18/2013.
  • On 8/2/2013 ResMed announced a quarterly dividend of $0.25 2.09% with an ex dividend date of 8/16/2013 which will be payable on 9/17/2013.
  • On 10/25/2013 ResMed announced a quarterly dividend of $0.25 2.02% with an ex dividend date of 11/15/2013 which will be payable on 12/18/2013.
  • On 1/24/2014 ResMed announced a quarterly dividend of $0.25 2.28% with an ex dividend date of 2/14/2014 which will be payable on 3/19/2014.
  • On 4/24/2014 ResMed announced a quarterly dividend of $0.25 2.11% with an ex dividend date of 5/16/2014 which will be payable on 6/17/2014.
  • On 8/1/2014 ResMed announced a quarterly dividend of $0.28 2.25% with an ex dividend date of 8/19/2014 which will be payable on 9/18/2014.

    • Recent Trading Activity for ResMed (NYSE:RMD)
    Shares of ResMed closed the previous trading session at 101.13 up +2.97 3.03% with 99.68000030517578 shares trading hands.